| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
DAPK2 |
DAPK2: Death-associated protein kinase 2 |
2.492 |
Evidence |
|
| KIF22 |
KIF22, KID, KNSL4: Kinesin-like protein KIF22 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.492 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
2.492 |
Evidence |
|
| TP53BP1 |
TP53BP1: Tumor suppressor p53-binding protein 1 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
2.492 |
Evidence |
|
| PPARA |
PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.492 |
Evidence |
|
| PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
MARK2 |
IPI00718858 |
2.492 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
F11R |
F11R, JAM1, UNQ264/PRO301, JCAM: Junctional adhesion molecule A precursor |
2.492 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
PRKAA1 |
IPI00011891 |
2.492 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
KIF1C |
IPI00556529 |
2.492 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
ZAK |
MLTK, ZAK, HCCS4: Mitogen-activated protein kinase kinase kinase MLT |
2.492 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
2.492 |
Evidence |
|
| RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
AANAT |
AANAT, SNAT: Serotonin N-acetyltransferase |
2.492 |
Evidence |
|
| LIMK1 |
LIMK1, LIMK: LIM domain kinase 1 |
NAT1 |
NAT1, AAC1: Arylamine N-acetyltransferase 1 |
2.492 |
Evidence |
|
| COPA |
COPA: Coatomer subunit alpha |
GRLF1 |
IPI00477498 |
2.492 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
EEA1 |
EEA1, ZFYVE2: Early endosome antigen 1 |
2.492 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.492 |
Evidence |
|
| MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
2.492 |
Evidence |
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
GNB2L1 |
Lung cancer oncogene 7 |
2.492 |
Evidence |
|
| MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
2.492 |
Evidence |
|
| MKI67 |
MKI67: Antigen KI-67 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.492 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
2.492 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
STOML2 |
STOML2, SLP2, HSPC108: Stomatin-like protein 2 |
2.492 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.492 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
2.492 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.492 |
Evidence |
|